Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Kura Oncology Cmn (KURA)

8.50 +0.65 (+8.28%)

6/26/2017  2:53pm

Open:

7.70

Pre. Close:

7.85

High:

8.60

Low:

7.50

Volume:

61,686

Market Cap:

167.17M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.59 - 8.75

8.75 - 9.22

Low:

6.84 - 6.93

6.93 - 7.19

Close:

7.55 - 7.79

7.79 - 8.49

Technical analysis  (as of: 2017-06-26 2:30:58 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 10.53     One year: 11.91

Support:

Support1: 7.10    Support2: 5.91

Resistance:

Resistance1: 9.02    Resistance2: 10.20

Pivot:

7.94

Moving Averages:

MA(5): 7.73     MA(20): 8.21

MA(100): 8.59     MA(250): 6.60

MACD:

MACD(12,26): -0.35     Signal(12,26,9): -0.40

%K %D:

%K(14,3): 46.83     %D(3): 29.03

RSI:

RSI(14): 51.83

52-Week:

High: 12.10  Low: 2.50  Change(%): 214.8

Average Vol(K):

3-Month: 114  10-Days 204

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
KURA has closed below upper band by 19.8%. Bollinger Bands are 12.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 26 Jun 2017 11:26:15 GMT
Kura Oncology Added to Russell 3000® Index

Tue, 27 Oct 2015 00:59:41 GMT
7.85

Sat, 31 Oct 2015 14:25:16 GMT
Kura Oncology Inc. KURA (US: Nasdaq)

Mon, 30 Mar 2015 15:01:06 GMT
Kura Oncology's Menin-MLL Inhibitor Program Shows Promise in Study Published ...

Mon, 15 May 2017 23:26:15 GMT
Kura Oncology's (KURA) CEO Troy Wilson on Q1 2017 Results - Earnings Call ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

21.41

Shares Float (M)

10.66

% Held by Insiders

% Held by Institutions

Shares Short (K)

465

Shares Short Prior Month (K)

430

Stock Financials

EPS

-1.500

EPS Est. Current Year

-1.630

EPS Est. Next Year

-2.050

EPS Est. Next Quarter

-0.430

Forward EPS

-2.049

Book Value (p.s.)

2.550

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-25.5

Return on Equity (ttm)

-45.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.352

Qtrly Earnings Growth

Operating Cash Flow (M)

-26.66

Levered Free Cash Flow (M)

-16.14

FoxReading.com

Valuation

P/E

-5.67

P/E Growth Ratio

0.08

P/BV

3.33

P/S

P/CF

-6.83

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.